Pharma finally boots up but still too robotic for social web
This article was originally published in Scrip
It holds the promise of progress for the pharma industry, from providing a platform for efficient and authoritative information, improving relations with the public, reaching a worldwide audience in just a click and even aiding recruitment and proceedings of clinical trials. But has pharma finally harpooned the giant that is social media?
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.